Financials
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -206.0% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 8.7 | n/a |
Pr/Book | 0.6 |
Latest | F'cast | |
---|---|---|
Revenue | 44.4% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-18 | 0.24 | (4.07) | (48.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-19 | 0.74 | (3.63) | (43.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 0.39 | (2.38) | (2.90)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.26 | (2.92) | (13.20)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 1.82 | (3.71) | (13.90)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Investment in Wanda, related party transactions | 28-May-2024 | 07:00 | RNS |
PDS Biotech: Business Update and Q1 2024 Results | 15-May-2024 | 14:32 | RNS |
Martlet Capital: mandate and acquisition | 13-May-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 66.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 72.00 |
52 Week Low | 49.00 |
Volume | 24,565 |
Shares Issued | 23.95m |
Market Cap | £15.92m |
RiskGrade | 410 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
12:00 | 3,701 @ 67.37p |
10:38 | 735 @ 67.40p |
09:08 | 20,000 @ 65.00p |
09:05 | 129 @ 68.00p |
CEO | Ilian Iliev |
CFO | Stephen Crowe |
You are here: research